Alberto Mazza, Gianni Bregola, Enrico Cavazzin, Fabio Dell'avvocata, Massimo Giordan, Gianluca Rigatelli, Marinella Rosini, Bruno Bignardi, Antonio Bragiotto, Tiziano Crino, Gabriella Chieregato, Roberto Fante, Mauro Favaron, Matteo Lazzarin, Ettore Petracca, Michele Roccato, Silvia Sartorello, Giovanni Scanavacca, Maria Lucia Zaramella, Stefano Cuppini
OBJECTIVE: Hypertension and hyper-cholesterolaemia is a dangerous combination frequently found in clinical practice. Despite a wide range of medications available for these both conditions, a large proportion of treated patients remain uncontrolled. We aimed to evaluate the cost-effectiveness treatment of a polypill in high-risk hypertensive and hyper-cholesterolemic subjects. DESIGN AND METHOD: 46 subjects (mean age 67.4 ± 11.5 years, 69.6% men) treated a with free-combination (FCT) of statins (atorvastatin 63...
June 1, 2022: Journal of Hypertension